Palomar Holdings CEO Mac Armstrong sells $580k in stock

Palomar Holdings (PLMR) CEO Mac Armstrong sold 5,000 shares totaling $580,090 on September 22, 2025, despite the insurer reporting strong Q2 2025 results that surpassed analyst expectations for both EPS and revenue. While the company exhibits robust 53% revenue growth and strong financial health, several analysts, including JPMorgan and Piper Sandler, have adjusted their price targets downwards, citing concerns over slower segment growth and higher expense ratios, indicating a nuanced outlook for the stock despite its perceived undervaluation.

Analysis

Palomar Holdings (PLMR) presents a mixed but fundamentally strong picture for investors. The primary event, a $580,090 stock sale by CEO Mac Armstrong, represents a very small fraction of his total direct and indirect holdings of over 445,000 shares, mitigating concerns of a significant loss of insider confidence. This action contrasts sharply with the company's robust operational performance, highlighted by 53% revenue growth over the last twelve months and a strong Q2 2025 earnings report where EPS of $1.76 and revenue of $496.3 million beat analyst expectations. Despite this financial strength and an InvestingPro assessment suggesting the stock is undervalued, the share price has declined 14% over the past six months. This weakness is likely influenced by recent downward price target revisions from analysts at JPMorgan, Keefe, Bruyette & Woods, and Piper Sandler. While these analysts maintain positive ratings like 'Overweight' and 'Outperform', their revised targets reflect specific concerns over decelerating growth in the earthquake insurance segment and a higher-than-expected expense ratio, creating a nuanced outlook where strong reported growth is tempered by forward-looking operational questions.

Key Decisions for Investors

• Investors should contextualize the CEO's stock sale as a minor transaction relative to his substantial total holdings, likely not indicative of a change in his long-term view of the company.
• The core decision involves weighing Palomar's demonstrated fundamental strength, including a 53% TTM revenue growth and recent earnings beat, against specific, forward-looking risks identified by analysts, such as slowing segment growth and rising expense ratios.
• Given that revised analyst price targets remain significantly above the current trading price, investors could assess whether the recent 14% stock decline has overly discounted these operational concerns, potentially creating a value opportunity if the company maintains its growth trajectory.